Articles On Avita Medical (ASX:AVH)

With the year coming to a close, I thought it would be interesting to look at 2019 in terms of some of the movements we saw in the ASX300 and its constituents. While there are still 2 weeks to go, we enter 2020 vastly different to how we st...

The Opthea Ltd (ASX: OPT) share price has been one of the best performers on the All Ordinaries in 2019. Since the start of the year the shares of the developer of novel biologic therapies for the treatment of eye diseases have gained a ma...

The S&P/ASX 200 index closed lower, down 23.1 points or 0.34 per cent at 6,706.9 points relative to the last close. The All Ordinaries index was lower by 0.36 per cent or 24.3 points to close at 6,812.1 points. Some of the best & w...

At lunch on Tuesday the S&P/ASX 200 index is trading ever so slightly higher. The benchmark index is up a few points to 6,732.5 points at the time of writing. Here’s what has been happening on the market today: Bank shares lower.   The...

The introduction of innovative technologies in the health care sector has entirely transformed the industry and has appeared as a boon for patients, clinicians, researchers and scientists.  Health care expenditure is increasing at the globa...

The S&P/ASX 200 index closed higher, ending 23 points or 0.34 per cent higher at 6,730 points relative to the last close. The All Ordinaries index was higher by 0.33 per cent or 22.9 points to close at 6,836.4 points. Some of the best...

Capital growth occurs when share prices to increase in value, and in 2019 we have seen some shares soar to new heights. Here we take a look at 3 ASX shares that have tripled in value (or more) in 2019. WISR Ltd (ASX: WZR) Currently trading...

Carrie LaFrenz published an article in the Australian Financial Review discussing how Avita Medical’s spray-on skin product is revolutionising care for burn patients. Carrie draws on Joseph’s comment that they are right on path with the rei...

If you’re anything like me, you’re probably looking to invest better in 2020. While 2019 has been a bumper year for the S&P/ASX 200 (INDEXASX: XJO), I’m always looking to improve my returns. The good news is, by considering the tax imp...

Australian equities are very sensitive to the performance of global economy as well as to the health of Australian economy. A rise in economic uncertainties might weigh over the sentiments of the market players and they might decide to make...

Health care system in Australia ranks well internationally with the presence of big pharmaceutical companies. With the push created by improvements in medical technology, such as advances in diagnostic and therapeutic-new radiological scann...

The S&P/ASX 200 index closed higher, ending 24 points or 0.36 per cent higher at 6,707 points relative to the last close. And, the All Ordinaries index higher by 0.33 per cent or 22.4 points to close at 6,813.5 points. Some of the best...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.36% to...

Sometimes value is visible in plain sight. Avita Medical’s (ASX: AVH) RECELL technology solution for burns patients represents the commercialisation of the invention of West Australian Fiona Wood. Instead of harvesting large amounts of skin...

The S&P/ASX 200 index closed lower, ending 105.8 points or 1.6 per cent lower at 6,606.5 points relative to the last close. And, the All Ordinaries index dropped by 1.55 per cent or 104 points to close at 6,714.4 points. The new vehicl...

The S&P/ASX 200 Index (INDEXASX: XJO) came crashing back to earth on Tuesday as it plummeted 2.19% lower. The ASX 200 closed at 6,712.30 points while the All Ordinaries Index (INDEXASX: XAO) dipped 2.11% to 6,818.40 points. That’s the...

The S&P/ASX 200 index closed lower, ending 150 points/ 2.23% lower at 6712.3 points relative to the last close. All Ordinaries index was down by 2.15%/ 146.9 points to close at 6,818.4 points.  Some of the best & worst performing s...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Tuesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 2.21% to ...

In afternoon trade the S&P/ASX 200 index is a sea of red. At the time of writing the benchmark index is down 2% to 6,721.8 points. Four shares that are falling more than most today are listed below. Here’s why they are sinking lower: T...

At lunch on Tuesday the S&P/ASX 200 index is on course to record a very disappointing decline. At the time of writing the benchmark index is down 1.7% to 6,743.8 points. Here’s what has been happening on the market today: ASX 200 notab...

On 2 December 2019, the S&P/ASX 200 Health Care Sector (XHJ) traded higher at 42,106.3 points, with a rise of 0.83% compared to the last close. The S&P/ASX 200 Index traded at 6,862.3 points, up by 0.24% from its previous close. YT...

Australian health care is a lucrative sector with strong growth prospects. Amid global worries, the health care sector gained tremendous attention from the investors in having the potential to generate huge profit in short span of time. In...

The best performer on the ASX 200 index this year has been the AVITA Medical Ltd (ASX: AVH) share price. Since the start of the year the global regenerative medicine company’s shares have gained a remarkable 686%. The next best performers...

The Australian Medicare is the foundation of the health care system since 1984 and has three major divisions- public hospitals, medical services and medicines. One of the essential parts of Medicare is the Pharmaceutical Benefits Scheme (PB...

In the Australian health care sector, the advancement in medical science have completely changed the health care services. New and advanced technologies have a high impact on medical and health services. These technologies are improving the...

AVITA Medical (ASX:AVH) and scientists at the Gates Center for Regenerative Medicine at the University of Colorado School of Medicine have announced a preclinical research collaboration.

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Monday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.33% to...

By Greg Peel Recovery It began with the Westpac ((WBC)) news on Wednesday which sent that stock into a spiral and sparked selling across the banks. That market cap weight impact triggered index selling that continued into Thursday mor...

18 Nov 2019 - Avita Medical (ASX:AVH) has appointed Mr David McIntyre as Chief Financial Officer.

In the share market past performance is no guide to future returns as the disclaimer goes. However, it can often be instructive. While on a risk-adjusted basis mid-cap or growth-style shares are often the best bet for growth. This is becau...

Dear time-poor reader: Preview to S&P December index re-weighting and long term trends reflected in index changes In this week's Weekly Insights (this is Part Two): -Positive Momentum Continues For CSL -Conviction Calls-Focus On Inde...

Australian regenerative medicine company AVITA Medical (ASX:AVH) has announced an institutional placement of $120 million to fund pipeline development of new indications.

It was another big day of trade on the ASX 200 on Wednesday as the benchmark Aussie index fell lower. The S&P/ASX 200 Index (INDEXASX: XJO) dropped 54.60 points (0.81%) to 6,698.40 in yesterday’s trade. Here’s a recap of 3 things you m...

The S&P/ASX 200 index is on course for another decline. In afternoon trade the benchmark index is down 0.5% to 6,717.4 points. Four shares that have fallen more than most today are listed below. Here’s why they are sinking lower: The A...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Regenerative medicine company Avita Medical is hoping to raise $100 million via an institutional placement. 

In the present age of digitization, digital health service sector has surfaced as one of the fastest-growing industries. Introduction of technologies in the health care domain has completely transformed the sector and has emerged out as a b...

In afternoon trade the S&P/ASX 200 index has given back its morning gains and dropped lower. At the time of writing the benchmark index is trading 0.2% lower at 6,714.3 points. Four shares that have not let that hold them back are list...

Shares in cancer-fighting biotech Immutep (ASX:IMM) have risen to eight-month highs today, on the back of positive interim data from its phase II clinical trial in patients with non-small cell lung cancer (NSCLC). Immutep is testing whether...

The AVITA Medical (ASX: AVH) share price is up more than 7.5% this morning after making an announcement. AVITA Medical is a regenerative medicine company with a technology platform to address unmet medical needs in burns, chronic wounds and...

The Avita Medical Ltd (ASX: AVH) share price could push higher on Friday after it became the latest addition to the ASX 200 index. Why is Avita Medical joining the ASX 200? After the market close on Thursday, S&P Dow Jones Indices anno...

The S&P/ASX 200 index returned to form on Thursday and pushed notably higher. The benchmark index finished the day 1% higher at 6,726.6 points. Will the local share market be able to build on this on Friday? Here are five things to wat...

Stock markets provide a platform to grow one’s money, as over time listed companies tend to grow in value, especially, investments in stable companies that are able to grow and tend to make profits for investors. Putting one’s money across...

Avita Medical Ltd (ASX: AVH) shares were up 8% on Friday, following a 60% increase in sales of its RECELL System, quarter for quarter.  As reported by the Australian Financial Review, broker Bell Potter on Friday upgraded Avita Medical fro...

Australian health care system is developing rapidly and is one of the best healthcare systems across the globe. It comprises of pharmaceutical manufacturing companies, biotech companies, medical device manufacturers & distributors, labo...

Avita Medical (AVH:AU) is a regenerative medical device company that produces the RECELL device for the treatment of burns. It is a company I have written about previously – and whilst being a recent addition to The Montgomery Fund portfoli...

October appears to be living up to its reputation as a volatile month on global markets after horror nights on Wall Street this week. Marketwatch.com’s Mark Decambre noted that Wall Street’s fear index was on track for the biggest rise to s...

Mesoblast limited (ASX: MSB) shares are locked in a trading halt today with the regenerative medicine business reportedly seeking to raise another $75 million according to news reports in the Australian Financial Review. Mesoblast has often...

AVITA Medical (ASX:AVH), a regenerative medicine company with a technology platform designed to address unmet medical need in therapeutic skin restoration, has announced that its American Depositary Shares ('ADS') have been approved...

Risk appetite may be bouncing back recently with the S&P/ASX 200 (Index:^AXJO) (ASX:XJO) index chalking up more than 20% gains since January, but this isn’t the time to get complacent. If you are looking for stocks to take profit on fo...